Recent Updates
Recently added Catalysts
CSTL Positive Sentiment Score: 75/100

Castle Biosciences to Release Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call on Thursday, Feb. 26, 2026

Thursday, February 5, 2026 2 min read
Key Takeaway: Castle Biosciences, Inc. will announce its fourth quarter and full-year 2025 financial results on February 26, 2026. The results will be shared after market close, followed by a conference call at 4:30 p.m. ET. Investors can access the call via phone or webcast, with a Q&A session included.

Market Sentiment Analysis

POSITIVE FACTORS

  • Castle Biosciences is set to release its financial results, indicating growth.
  • The company is focused on innovative tests that improve patient care.
  • Management will engage with investors through a conference call.

Full Press Release Details

FRIENDSWOOD, Texas, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the fourth quarter and year ended Dec. 31, 2025, after the close of market on Thursday, Feb. 26, 2026.
Company management will host a conference call and webcast to discuss its financial results at 4:30 p.m. Eastern time on the same day.
Conference Call and Webcast DetailsA live webcast of the conference call can be accessed here:https://events.q4inc.com/attendee/483643109, or via the webcast link on the Investor Relations page of the Company’s website:https://ir.castlebiosciences.com/overview/default.aspx. Please access the webcast at least 10 minutes before the conference call start time. A replay of the webcast will be available following the conclusion of the conference call.
To access the live conference call via phone, please dial 1 833 470 1428 from the United States, at least 10 minutes prior to the start of the call, using the access code 695618. International dial-in numbers are available here:https://www.netroadshow.com/events/global-numbers?confId=94133; please use the same access code above to join the call.
There will be a brief Question and Answer session following management commentary.
About Castle BiosciencesCastle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. With a primary focus in dermatologic and gastroenterological disease, we develop personalized, clinically actionable solutions that help improve disease management and patient outcomes.
We put people first—empowering patients and clinicians and informing care decisions through rigorous science and advanced molecular tests that support more confident treatment planning. To learn more, visitwww.CastleBiosciences.comand connect with us onLinkedIn,Instagram,FacebookandX.
DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, AdvanceAD-Tx, TissueCypher, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeqare trademarks of Castle Biosciences, Inc.

Investor Contact:Camilla Zuckeroczuckero@castlebiosciences.com

Media Contact:Allison Marshallamarshall@castlebiosciences.com

Source:Castle Biosciences Inc.

Frequently Asked Questions

When will Castle Biosciences release its Q4 2025 results?

Castle Biosciences will release its Q4 2025 financial results on February 26, 2026.

What time is the conference call for financial results?

The conference call will take place at 4:30 p.m. Eastern Time on February 26, 2026.

How can I access the conference call?

You can access the conference call via phone or through a live webcast.

Will there be a Q&A session during the call?

Yes, there will be a brief Question and Answer session following the management commentary.

Tags: CSTL Viatris Investor Conferences Healthcare Castle Biosciences financial results conference call Q4 2025
Last updated: Feb 5, 2026